Video & Transcript Research : 'FDA'

Page 14 of 62
VT

Vermont 2025-2026 Regular Session

House Session - 2026-03-18 - 2:32PM

Vermont House Floor Meeting

Transcript Highlights:
  • FDA FDA FDA has<02:34:24.680> an<02:34:24.800> initiative<02:34:25.640> of<02:34
  • <02:34:38.080> is<02:34:38.280> Operation Also now started by the FDA is Operation
  • Also now started by the FDA is Operation Stork<02:34:39.640> Speed, Stork Speed, Stork Speed,
  • FDA.
  • Quiet cuts to staffing and budgets at the FDA have the potential to weaken oversight even more.
Keywords: 926, house, all
Summary: The House resumed consideration of H.606 on firearm procedures and first took up Section 3 and its effective dates. A member from Northfield spoke at length in support, arguing the provision is narrowly tailored, based on actual dangerousness rather than mental illness alone, and is more limited than federal law because it applies only to specific court findings and is temporary, with rights restorable upon recovery. The House then approved Section 3 and its effective dates, approved the remainder of the Judiciary Committee report, and ordered third reading. The chamber then moved through third readings and passed H.385 on remedies and protections for victims of coerced debt, H.556 on exceptions to the state minimum wage, H.559 on the parole board, H.723 on posting of land, and H.757 on manufactured homes and limited equity cooperatives. On H.814, relating to neurological rights and AI in health and human services, the House adopted an amendment offered by the member from Burlington that required the advisory council to include proposed definitions for neurotechnology, artificial intelligence, and related terms in its report; the House Health Care Committee reported the amendment favorable 11-0-0, and the bill then passed. H.816, regulating the use of artificial intelligence in the provision of mental health services, also passed, as did H.927, technical corrections for the 2026 session. The House then took up H.930 on chronic absenteeism. The committee member from Manchester described the bill as an AOE proposal responding to high post-pandemic absenteeism rates and their impact on learning, and outlined provisions adding definitions, updating compulsory attendance language, requiring a state model policy, strengthening notification and truancy procedures, and preserving existing penalties. The member said the Education Committee heard from a wide range of education and child welfare witnesses and passed the bill 11-0. After a brief clarification on the absences section, the House proceeded toward third reading of H.930.
NH

New Hampshire 2025 Regular Session

House Health, Human Services and Elderly Affairs (04/09/2025)

Health, Human Services & Elderly Affairs

Transcript Highlights:
  • It's all determined by the FDA.
  • It's all determined by the FDA.
  • It's all determined by the FDA.
  • It's not restricted by practitioners prescribing and it's all determined by the FDA.
  • It's not restricted by practitioners prescribing and it's all determined by the FDA.
Keywords: 1189, house, all
OK

Oklahoma 2026 Regular Session

Agriculture and Wildlife Mar 2nd, 2026 at 10:00 am

Agriculture and Wildlife

Transcript Highlights:
  • Deli meats, fruits, vegetables, you know, things that actually go through USDA inspections, FDA inspections
  • we see right now, and that was a short little search on the FDA website, which actually, now I didn't
  • pages, but I didn't go all the way to the end to see, but I never saw any milk-related deaths on the FDA
MA

Massachusetts 2025-2026 Regular Session

Senate Session (Full Formal with Calendar) Jun 21st, 2026 at 11:00 am

Massachusetts Senate Floor Meeting

Transcript Highlights:
  • insurers and utilization review organizations from using prior authorization that restricts access to FDA-approved
  • insurers and utilization review organizations from using prior authorization that restricts access to FDA-approved
  • It restricts and delays access to FDA-approved medications for the treatment of serious mental illness
  • This amendment ensures that when a clinician prescribes an FDA-approved medication to treat SMI, an insurer
Keywords: 995, all
Summary: The Senate considered a series of amendments to a primary care health care bill and also took up a separate literacy bill. Several amendments were withdrawn, including one on artificial intelligence in health care and others related to cost controls, direct primary care, and provider studies. The Senate adopted amendments on preserving access to treatment for serious mental illness, modernizing the definition of primary care, clarifying payment rates for community health centers, excluding pharmaceutical spending from primary care expenditure calculations, and strengthening health equity reporting. Other amendments on rate bands, alternative payment systems, private equity reporting, scope of practice, and ownership disclosure were rejected. The Senate then approved the Ways and Means amendment and ordered the primary care bill to a third reading. The chamber also took up final passage of An Act Relative to Teachers Preparation and Student Literacy, with senators describing it as a long-awaited compromise focused on improving early reading outcomes. Supporters said the bill requires evidence-based K-3 literacy curricula, regular student screening and family notification, dyslexia screening protocols, professional development for teachers, and a free state-developed curriculum option. Senators emphasized the need to address declining third-grade reading proficiency and equity gaps. The bill passed to be enacted by a unanimous roll call and was sent to the Governor. After the literacy bill, the Senate returned to the primary care bill, where senators again debated cost containment, innovation, and access. The final version included the adopted amendments and was passed to be engrossed by a roll call vote of 35-4. The Senate then adopted an adjournment order and recessed, adjourning in memory of Henry Thomas III, former Representative Ben Swan, and Mr. Dennis Frane.
TX
Transcript Highlights:
  • More about these chemicals, and there's a whole discussion about the FDA and the broken, perverted process
  • Actually, I think the FDA... is going to see some changes.
  • The FDA doesn't even study them.
  • The FDA director under President Biden said he doesn't even know all the chemicals in our food because
Bills: SB 25, SB25, SB314
NH

New Hampshire 2025 Regular Session

House Ways and Means (01/21/2025)

Transcript Highlights:
  • So I'm not in charge of enforcing the FDA-approved cigarette products.
  • approved list of they're not on the FDA approved list of ecigarette<01:39:47.560> products<01
  • products is does the FDA get it all products is does the FDA get it all first<01:40:14.679> so
  • first so it all goes through the FDA first so it all goes through the FDA first<01:40:16.719>
  • it's contraband for tax purposes and it was not seized as contraband under the FDA.
Keywords: 928, house, all
Summary: The committee received an overview from Chris of the Legislative Budget Assistance Office on how it will estimate unrestricted revenues for the General Fund, Education Trust Fund, Highway Fund, and Fish and Game Fund. He explained that the committee’s work is based on current law, not pending bills, and that the estimates will feed into a House resolution and an amendment to House Bill 1, the operating budget. He also described the broader budget process, including how House and Senate estimates are reconciled, how surplus statements account for revenue changes from enacted bills, and how a committee of conference could resolve differences later in the session. No votes were taken. Members then asked about why the Education Trust Fund was running below plan. Chris said the shortfall appeared to be driven largely by business taxes, including differences in the BET/BPT split and improved tax-processing systems that better track where business tax payments belong. Representative Orr also asked about tobacco tax collections and out-of-state sales; Chris said tobacco revenue was likely overestimated in 2023 based on COVID-era patterns, with more people smoking at home, and noted that e-cigarette tax revenue goes to the General Fund while cigarette taxes are split between the General Fund and Education Trust Fund. He said he did not have a specific estimate for cross-border sales. Commissioner Lindsay St. Pierre of the Department of Revenue then began a deeper dive into the department’s role and the taxes it administers. She reviewed the department’s mission, organizational structure, taxpayer services, and the tax policy and legislative analysis staff who prepare fiscal notes and testify on bills. She noted that the department administers about $2.9 billion in revenue across major taxes such as business taxes, meals and rooms, and utility property tax, and that the figures being discussed were preliminary because the annual report had not yet been issued. The discussion was informational only, with no formal action taken.
FL

Florida 2026 Regular Session

Children, Families, and Elder Affairs Jan 12th, 2026

Children, Families, and Elder Affairs

Transcript Highlights:
  • You go to the FDA website, the pharmaceutical inserts, and website...
  • You go to the FDA website, the pharmaceutical inserts and website, and this is what you find on this
  • and, if diagnosed, be informed about what resources are available in the form of clinical trials and FDA-approved
  • and, if diagnosed, be informed about what resources are available in the form of clinical trials and FDA-approved
  • Just last year, the FDA approved two blood tests to help in the diagnosis of Alzheimer's.
Bills: S0042, S0578, S0624, S7018
Summary: The committee met with a quorum and first heard SB 624, which would codify DCF’s current practice of allowing batterers intervention programs to offer supplemental faith-based activities so long as participation is voluntary. The bill drew support from faith-based and family organizations, which argued it would restore access to effective rehabilitation options and remove discriminatory barriers. SB 624 was reported favorably after a roll call vote. The committee then heard SB 42, which would require child protective investigators and child protection teams to rely on qualified medical professionals when a child has a documented pre-existing diagnosis or when a parent requests an exam, and would require clearer notice to parents and custodians at the start of an investigation. Testimony overwhelmingly came from parents, advocates, and disability rights representatives describing cases in which medically complex children were allegedly misdiagnosed as abuse victims and families were separated unnecessarily. Members expressed sympathy and support, and SB 42 was reported favorably. Next, the committee considered CS/SB 578, creating an Alzheimer’s disease awareness initiative within the Department of Elder Affairs to promote early detection, brain health education, research updates, and clinical trial awareness, with outreach focused on older adults and at-risk populations. An amendment was adopted to place the campaign within the Alzheimer’s Disease Initiative. A caregiver testified about the need for public education and early diagnosis, and the bill was reported favorably. The committee also took up SPB 7018, a committee bill on child welfare that would extend the definition of “visitor” for foster homes to reduce repeated background checks, make the Step Into Success foster youth workforce pilot permanent and statewide, and create a program through the Florida Institute for Child Welfare to catalog best practices among community-based care lead agencies. The bill was approved as a committee bill and reported favorably. Finally, the Department of Children and Families presented its 2025-26 final funding methodology and rates report for community-based care. Members questioned the proposed tiered model, including insurance costs, risk corridors, prevention funding, performance measures, and regional funding disparities. No vote was taken on the presentation, but members discussed the possible need for follow-up legislation and additional stakeholder input.
CA
Transcript Highlights:
  • California, specifically mifepristone, a common and safe medication abortion drug first approved by the FDA
  • It's the least invasive option for abortion care based on decades of FDA research.
  • It's because the FDA, under political pressure, has stripped away nearly all original safety protocols
  • Originally, the FDA required that mifepristone only be dispensed in person by a certified physician after
  • Originally, the FDA required that mifepristone only be dispensed in person by a certified physician after
Summary: The Assembly Business and Professions Committee heard a full agenda of bills focused on reproductive health, professional licensing and sunset reviews, consumer protection, and business regulation. Early testimony centered on AB 260, which would protect access to medication abortion, mifepristone, and telehealth reproductive care in California; supporters emphasized state protections against federal restrictions, while an opponent argued the bill removed safety safeguards. The committee also heard AB 714 on closing a loophole in regulation of low-cost commercial driving schools, AB 968 on allowing pharmacists to prescribe non-hormonal contraception, AB 671 on streamlining restaurant permitting, AB 1027 on strengthening cannabis product testing oversight, AB 1271 on broadband pricing and speed transparency, and AB 1332 on narrowly allowing medicinal cannabis shipments for seriously ill patients. Several sunset bills were also taken up, including AB 1482 on animal shelter and breeder transparency, AB 1501 on the Podiatric Medical Board and Physician Assistant Board, AB 1502 on the Veterinary Medical Board, AB 1503 on the Board of Pharmacy, and AB 1504 on the Massage Therapy Council. Testimony was largely in support of the measures, with many bills drawing co-sponsors or support from industry, consumer, or professional groups. AB 1503 generated the most sustained opposition, with nurses, physicians, and drug industry representatives objecting to expanded pharmacy technician ratios, standard-of-care language, and therapeutic interchange authority; supporters argued the bill would modernize pharmacy practice and expand access. AB 1504 also drew mixed testimony, with massage therapy groups supporting continuation of the council but raising concerns about proposed public records and governance provisions. AB 1271 drew a policy dispute over whether broadband reporting requirements duplicated federal FCC processes, while supporters argued California needed its own consumer-facing data and complaint system. After quorum was established later in the hearing, the committee began taking roll-call votes. AB 1271, AB 1332, AB 1482, AB 1501, and AB 1502 were all reported out on due-pass motions, with AB 1271 amended and the others generally amended or as introduced as noted. Earlier bills including AB 260, AB 671, AB 714, AB 968, and AB 1027 also received motions and were approved once the quorum was present. The chair repeatedly noted the lack of quorum during the hearing, but once one was secured, the committee completed votes on the agenda items and advanced the measures to Appropriations.
FL

Florida 2025 Regular Session

March 20, 2025 - 02:00 PM

Transcript Highlights:
  • Although there's not any cure, there are currently eight FDA-approved therapies for Duchenne, with many
  • With an FDA-authorized test. genetic counseling, and care.
  • With an FDA-authorized test already available, Florida has the opportunity to expand its newborn screening
  • Currently, there are eight FDA-approved medications to treat Duchenne, and there are more than 40 in
  • want to highlight some of the comments that were made from the public testimony that there are eight FDA-approved
Summary: The subcommittee met with a quorum present and took up five health-related bills. HB 1089, which would add Duchenne muscular dystrophy to Florida’s newborn screening panel, was presented as a way to enable earlier diagnosis and treatment; a pediatric neurologist from Nemours testified in support, noting existing FDA-approved therapies and ongoing clinical trials. After supportive debate, the bill passed 17-0 and was reported favorably. HB 1083 would standardize patient access to medical records by setting deadlines for providers to produce or allow inspection of records and requiring electronic delivery when available. Supporters said it would reduce delays in care and costs, while two industry groups appeared in opposition. Members from both parties spoke in favor, and the bill passed 17-0 and was reported favorably. HB 1297, which aligns Florida’s electronic prescribing rules more closely with federal law and removes some state exceptions, drew opposition from physicians who argued paper prescriptions are still needed for emergencies, shortages, and price shopping. The sponsor said the bill’s goals were patient safety, fraud prevention, and efficiency; despite concerns, it passed 18-0 and was reported favorably. The committee then considered PCS for HB 1421, the Emily Adkins Family Protection Act, which would create a statewide blood clot and pulmonary embolism registry, require hospital reporting and risk-assessment policies, and expand training requirements in hospitals, nursing homes, and assisted living facilities. The bill was presented with emotional testimony from Emily Adkins’ parents, who urged support and co-sponsorship in her memory. Members from both parties praised the family’s advocacy, and the PCS passed 18-0 and was reported favorably. Finally, HB 449 on optometry would expand optometrists’ authority to prescribe certain medications and perform specified laser and non-laser eye procedures after certification. The bill and amendment drew strong opposition from ophthalmologists and their association, who raised patient-safety, training, and delegation concerns, while optometrists argued the bill would improve access, especially in rural areas and counties without ophthalmologists. The amendment was adopted, and the bill as amended passed on a recorded vote and was reported favorably.
FL

Florida 2025 Regular Session

February 12, 2025 - 01:00 PM

Transcript Highlights:
  • We are FDA-certified facilities. We track all of the same information that the distributors track.
  • We are also registered with the FDA. FDA can come in and... ...and test it.
  • We are also registered with the FDA. FDA can come in and do a visual inspection any time.
Summary: The committee met to hear an overview of Florida’s alcoholic beverage regulatory structure and a panel discussion on the state’s three-tier system. Emily Oglesby of DBPR explained the department’s licensing and enforcement roles, described common license types, and outlined the three tiers—manufacturers, distributors, and retailers—along with tied-house restrictions and several statutory exceptions for certified Florida farm wineries, breweries with tap rooms, brew pubs, and craft distilleries. Members asked about licensing fees, the number and classification of distributors and craft producers, and how the exceptions fit within the broader system. Panelists from craft breweries, craft distilleries, wholesalers, and retailers then discussed how the system affects market access, pricing, and product selection. Craft producers argued that Florida’s rules make it difficult for small brands to reach retailers because they must rely on distributors that often prioritize larger, higher-volume products; they said limited self-distribution or other reforms could help small businesses grow without eliminating wholesalers. Wholesalers and retailers defended the three-tier model as a public-safety and anti-monopoly framework, emphasizing investment in warehousing, sales, compliance, and product vetting, while noting that they already carry some craft products and make selections based on demand, quality, and shelf space. Members also explored related issues such as direct-to-consumer sales, the role of excise-tax audits and inspections, and the emerging market for hemp-derived THC beverages and other alternative drinks. DBPR and industry witnesses said alcohol and hemp products are regulated differently, and several speakers urged the Legislature to consider clearer rules for these products. The meeting ended with no bill vote or formal action; the chair thanked the panel and adjourned after Representative Yeager moved to rise, with no objection.
MN

Minnesota 2025-2026 Regular Session

House Public Safety Finance and Policy Committee 3/17/26

Public Safety Finance and Policy

Transcript Highlights:
  • Uh, on July 29th of 2025, FDA Commissioner McCary publicly announced that there was a problem in the
  • Uh on July 29th of 2025, FDA important.
  • So, anyway, being that the synthetics are on the rise, I think this this is so important what the FDA
  • So, anyway, being that the synthetics are on the rise, I think this this is so important what the FDA
  • So, anyway, being that the synthetics are on the rise, I think this this is so important what the FDA
HI

Hawaii 2026 Regular Session

CPC Public Hearing - Tue Mar 3, 2026 @ 2:00 PM HST

Consumer Protection & Commerce

Transcript Highlights:
  • that is labeled in accordance with FDA that is labeled in accordance with FDA guidelines<00:17:53.360
  • It goes through FDA extensive testing.
  • <00:20:01.560> gives<00:20:01.880> you The difference is that the FDA gives you The
  • <00:21:50.840> Each goes through FDA extensive testing.
  • Each goes through FDA extensive testing.
Summary: The committee heard several administration bills related largely to workers’ compensation and unemployment insurance. On HB 2323 HD1, which would modernize workers’ compensation notice and filing procedures, DLIR and other agencies testified in support of the original bill language but said HD1 removed key components and weakened the bill’s clarity and continuity. HB 2324 HD1, which would repeal state hoisting-machine certification requirements and the separate crane operator certificate, drew support from DLIR; members asked about whether the change would affect safety or local operators, and DLIR said OSHA-compliant certifications already exist and the union supported the change. HB 1509 HD1, which would require faster employer responses to treatment plans and impose penalties for nonresponse, received support from DLIR and others, while DHRD said it wanted an amendment. The committee also took up HB 2164 HD1 on compounded prescription drugs in workers’ compensation. DLIR supported the bill as a way to define compounded drugs and curb inflated pricing, but DHRD and a medical provider opposed it and asked for amendments. Testimony focused heavily on whether the definition should include 503B compounding facilities and whether physician dispensing should be limited to the first 30 days after injury. HB 2165 HD1, dealing with unemployment insurance eligibility and removing the two-year limit on recouping overpayments, was supported by DLIR but opposed by Unite Here Local 5, which argued it would make it harder for striking workers and other claimants. Members questioned the impact of changing reporting deadlines from calendar days to business days and raised concerns about future benefit offsets; DLIR said the bill was needed for federal conformity and that the committee would revisit the offset percentage and effective date. Later, the committee heard HB 2367 on pay transparency, requiring salary ranges in job postings and removing the small-employer exemption. The Hawaii Civil Rights Commission, AAUW, Hawaii Women Lawyers, and an individual testifier supported the bill, saying pay transparency promotes fairness, trust, and pay equity; one testifier described being underpaid compared with a predecessor and said posting ranges would save applicants’ time. HB 2619 HD1, concerning homemade food products and farm kitchens, received generally supportive comments from the Department of Health, which requested an amendment to preserve flexibility in future rulemaking. HB 1765 HD1, on spear-fishing safety warnings, drew support from a safety educator and comments from DLNR; supporters said warning labels would help prevent hypoxic blackout deaths and were low-cost and easy to implement. No votes or final committee actions were taken in the portion of the meeting provided.
FL
Transcript Highlights:
  • WE WANT TO JOIN YOU AND SENATOR BURGESS APPLAUDING THE FDA AS THE BROAD SUPPORT FOR VETERANS AND FOR
  • THE FDA HAS STATUTORY OVERSIGHT OF US KNOW 990 FORMS CAN BE LOCATED AT THE HEALTH FLORIDA VETS.org WEBSITE
  • , WE WILL POINT YOU IN THE RIGHT DIRECTION AND IF WE CAN HELP YOU WE HAVE FRIENDS AT CAREER SOURCE, FDA
  • WE OPERATE IN A WORLD OF CAREER SOURCE AND COMMERCE IN SPACE FLORIDA, BUT WE ARE UNDER FDA FOR REASON
Keywords: 999, senate, all
UT

Utah 2025 2nd Special Session

Business and Labor Interim Committee - November 19, 2025

Business and Labor Interim Committee

Transcript Highlights:
  • Why are we changing the license to a mandatory certificate, especially given the FDA regulation specifically
  • certification registration processes in New York and Pennsylvania cited by OPLER predated the 2022 FDA
  • Yeah, I'm sorry if I missed it, but I've gotten some emails saying that the FDA requires licensure for
  • I've gotten some emails saying that the FDA requires licensure for hearing aids.
  • There's guidance from both of those states and then from the FDA saying this should not change who is
Keywords: 985, all
OK

Oklahoma 2026 Regular Session

Business and Insurance 2ND REVISED Apr 16th, 2026 at 09:30 am

Business and Insurance

Transcript Highlights:
  • has a certificate that they're their The product is a safer choice, and they had to go through the FDA
  • my explanation that these premium products are trying to do things right and have jumped through the FDA
  • , it would incentivize these other products to go through what Copenhagen has gone through with the FDA
AL

Alabama 2025 Regular Session

Alabama Senate Healthcare Committee Mar 19th, 2025

Healthcare

Transcript Highlights:
  • In a recent 13-month period, the FDA and the National Poison Control have seen an uptick in...
  • I'd also like to make the point that the only FDA-approved cannabis product is Marinol and... ...approved
  • The FDA says synthesized THC is good, so they approved it. And that's Marinol.
Bills: HB194, SB87, SB237
NH

New Hampshire 2026 Regular Session

Senate Health and Human Services (05/06/2026)

Health and Human Services

Transcript Highlights:
  • treatments that may not be, uh, have gone through and completed the full drug approval process from FDA
  • :22:39.960> approval<00:22:40.280> process<00:22:40.800> from<00:22:40.920> FDA
  • ,<00:22:41.560> which drug approval process from FDA, which drug approval process from FDA
Keywords: 1191, senate, all
AZ

Arizona 2026 Regular Session

01/27/2026 - Senate Appropriations, Transportation and Technology

Appropriations, Transportation and Technology

Transcript Highlights:
  • So is this the kind of thing that gets an FDA approval or? They're FDA cleared.
  • All of the devices are FDA cleared. And the proof is about 10 studies that have been public...
  • The devices are FDA cleared, then the proof is about 10 studies that have been published in J.
Summary: The Senate Health and Human Services Committee heard and advanced six measures. SB 1118, as amended, appropriates $3 million to the Department of Health Services for grants to rural hospitals to install radiation protection systems in cardiac catheterization rooms; testimony focused on protecting health care workers from ionizing radiation, with the amendment narrowing the bill from an unspecified appropriation to a specific amount and room type. The committee also approved SB 1154, a $500,000 General Fund appropriation for an ADOT traffic and safety study on SR 64 between Williams and the Grand Canyon, after testimony from local officials, law enforcement, and fire personnel describing heavy tourism traffic, crashes, and fatalities. SB 1063, which appropriates $10.4 million for safety improvements on U.S. Route 70, also received a do-pass recommendation after testimony from the San Carlos Apache Tribe, sheriffs, and tribal law enforcement describing a high number of fatalities and dangerous roadway conditions. The committee then passed SB 1153, which creates a Grand Canyon National Park specialty license plate and fund; the Grand Canyon Conservancy testified that proceeds would support park conservation, research, education, and preservation work. SCM 1001, as amended, urging the renaming of State Route 260 as the Donald J. Trump Highway, was approved after a contentious debate over the symbolism of the memorial. Finally, SB 1209, which exempts people without a residence address or whose address is a homeless shelter from non-operating ID license fees and extends the validity period for those IDs, received a do-pass recommendation after testimony from homeless services providers that IDs are essential for housing, employment, and access to services. Votes were 10-0 for SB 1118, 6-4 for SB 1154, 6-4 for SB 1063, 10-0 for SB 1153, 6-4 for SCM 1001, and 9-0 with one not voting for SB 1209.
VT

Vermont 2025-2026 Regular Session

House Session - 2026-03-19 - 1:00PM

Vermont House Floor Meeting

Transcript Highlights:
  • The FDA announced its intent to set formula-specific action levels as part of Operation Stork Speed,
  • that the FDA is involved in right now. that the FDA is involved in right now.
  • The<00:25:24.920> FDA<00:25:25.440> announced<00:25:26.800> its<00:25:27.000>
  • intent<00:25:27.560> to<00:25:27.679> set The FDA announced its intent to set The
  • report from the FDA. report from the FDA.
Keywords: 926, house, all
Summary: The House began with routine business, including referral of Senate Bill 211 on motor vehicle inspections to the Transportation Committee and Senate Bill 298 creating the Vermont Voting Rights Act to the Committee on Government Operations and Military Affairs. The chamber also referred House bills reported by Ways and Means to Appropriations, including H. 211 on data brokers and personal information and H. 931 on miscellaneous education law changes. JRH9, a joint resolution urging the American Speech-Language-Hearing Association to reconsider its opposition to rapid prompting method communication instruction for students with apraxia of speech or autism, was read and referred to Human Services. Several announcements followed, including a welcome to members of the Vermont chapter of the American Physical Therapy Association, a reminder about an education reform meeting, and a correction regarding a prior reference to S. 138 of 2023 and the working group on student protections from harassment and discrimination in schools. The House also recognized guests in the gallery, including Donnie Kanovsky, who was described as a proponent of JRH9. The Speaker announced that H. 606 on firearms procedures, H. 642 on youthful offender proceedings, and later H. 585 would be bumped to later in the calendar. The House then took up H. 537, the right to grow vegetable gardens. The committee explained the bill would protect vegetable gardening in common interest communities and rental housing, while allowing reasonable restrictions and landlord or association oversight; witnesses included a South Burlington resident, HOA and landlord representatives, and legislative counsel. The committee reported an 8-0-0 vote, the House adopted the committee amendment, and ordered third reading. The chamber then passed H. 171 on Attorney General investigations into a law enforcement officer’s use of a firearm and H. 519 allowing Randolph police officers to enroll in Group C of the state retirement system. The House also passed H. 536 on toxic heavy metals in baby food products after extended debate over whether infant formula should be included. Supporters said the bill would help parents make informed choices and noted the amendment was intended to align with federal action; opponents argued formula-specific federal work was still underway and urged waiting. The chamber then passed H. 550 on gender equity in correctional facilities, H. 733 on franchise agreements, H. 775 on housing production tools, H. 887 on crime victim status under the Fair Employment Practices Act, H. 917 on military affairs, and H. 921 on alcoholic beverages. Action on H. 930 addressing chronic absenteeism was postponed one legislative day, and H. 942 on miscellaneous agricultural subjects began second reading with the committee outlining sections on water quality training, non-sewage waste management, and unit pricing.
MS

Mississippi 2026 Regular Session

Appropriations - Room 409, 28 January, 2026; 1:30 P.M.

Appropriations

Transcript Highlights:
  • We have federal rules, lots of federal rules with FDA, DEA, um, any of the other federal agencies that
  • <00:02:01.680> federal<00:02:02.000> rules<00:02:02.240> with<00:02:02.399> FDA
  • c><00:02:02.880> DEA,<00:02:04.159> um<00:02:04.880> any of federal rules with FDA
  • , DEA, um any of federal rules with FDA, DEA, um any any<00:02:05.520> of<00:02:05.600> the
  • has a pathway for some so the FDA has a pathway for some compounding<00:02:46.959> and<00:02:
Summary: The committee heard budget presentations from the Mississippi Board of Pharmacy and the Mississippi State Board of Chiropractic Examiners, followed by the physical therapy board. The Pharmacy Board said it licenses pharmacists, technicians, students, and many facilities and supply-chain entities, including wholesalers, manufacturers, 3PLs, PBMs, and nonresident compounders. Its main requests were a 3% salary increase for specialized staff, about $118,000 for contract help to evaluate pharmacists with substance abuse or mental health issues under a recently passed public health bill, and additional IT spending authority for system upgrades and cloud migration. Members discussed the board’s role in protecting the public, vetting out-of-state facilities, and the need to keep sensitive data secure; no vote was taken. The Chiropractic Examiners board described itself as a small, contract-staffed agency with about 700 active licenses and a database system that is no longer supported by Microsoft. It said it had requested about $173,000, but the legislative budget recommendation was $134,000, and it needs roughly $40,000 more to upgrade or rebuild the system, including security fixes and online renewal capability. Members focused on the cybersecurity risk of using unsupported software and the need to protect personal information; the board also noted that its licensing data does not include banking information because payments are handled through the state portal. The Physical Therapy Board said it regulates physical therapists and physical therapist assistants, with 4,242 licenses and 252 complaints in the last fiscal year, and that demand for the profession continues to grow. Its requests included $6,000 in salary progression for long-serving staff, about $360 more in PDM salary authority, and roughly $38,610 for a one-time upgrade to its LMS licensing system, plus related cloud-migration costs. Senators noted the board’s strong reputation, discussed the burden of annual or biennial renewals, and supported the technology upgrade because the current system is no longer supported and could create liability risks if not addressed.